Figure 10

Example of an application of the EFLCM method: To screen the effect of 30 different anti-cancer drugs, preprinted on a 384-well plate and incubated for three days with primary tumor cells from one patient. Using live/dead fluorescence cell discrimination to determine a drug sensitivity profile for primary human tumor cells with the aim of assisting individualized assay guided cancer therapy.